Page last updated: 2024-08-21

perflexane and Ventricular Dysfunction, Left

perflexane has been researched along with Ventricular Dysfunction, Left in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dittrich, HC; Hall, G; Kitzman, DW; Nanda, NC1

Trials

1 trial(s) available for perflexane and Ventricular Dysfunction, Left

ArticleYear
Imagent improves endocardial border delineation, inter-reader agreement, and the accuracy of segmental wall motion assessment.
    Echocardiography (Mount Kisco, N.Y.), 2003, Volume: 20, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Echocardiography, Doppler; Endocardium; Female; Fluorocarbons; Humans; Hydrocarbons, Brominated; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Observer Variation; Probability; Prospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Single-Blind Method; Ventricular Dysfunction, Left

2003